Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A acute monocytic leukemia that occurs in an adult.
Biomarker and diagnostic research for adult acute monocytic leukemia has been reported in the published literature.
7 clinical trials registered, 3 recruiting. Interventions under study include drug therapy, other interventions, gene therapy, and procedural interventions. Pipeline includes 5 PHASE2, 1 PHASE1. Research is sponsored by a mix of industry and academic institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT06950034](https://clinicaltrials.gov/study/NCT06950034) |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:52 AM UTC
Common questions about adult acute monocytic leukemia
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML) |
PHASE1 |
Solu Therapeutics, Inc |
RECRUITING |
[NCT00898456](https://clinicaltrials.gov/study/NCT00898456) | Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia | — | Alliance for Clinical Trials in Oncology | UNKNOWN |
[NCT06504459](https://clinicaltrials.gov/study/NCT06504459) | Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML | PHASE2 | OHSU Knight Cancer Institute | UNKNOWN |
[NCT01627041](https://clinicaltrials.gov/study/NCT01627041) | Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia | PHASE2 | National Cancer Institute (NCI) | ACTIVE_NOT_RECRUITING |
[NCT00658814](https://clinicaltrials.gov/study/NCT00658814) | Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia | PHASE2 | National Cancer Institute (NCI) | ACTIVE_NOT_RECRUITING |
83 publications have been identified in PubMed for adult acute monocytic leukemia. Research spans Basic Science / Preclinical (57%), Case Report / Case Series (34%), and Gene Therapy / Novel Therapeutics (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 47 | 57% |
Patient case studies | 28 | 34% |
New treatment approaches | 6 | 7% |
Testing and diagnosis research | 1 | 1% |
Disease patterns and progression | 1 | 1% |
Chen AL (2026). [PMID: 42021693](https://pubmed.ncbi.nlm.nih.gov/42021693/). *Haematologica*. [Basic Science / Preclinical]
Ji HL (2026). [PMID: 41971738](https://pubmed.ncbi.nlm.nih.gov/41971738/). *Front Fungal Biol*. [Case Report / Case Series]
Li Y (2026). [PMID: 41704870](https://pubmed.ncbi.nlm.nih.gov/41704870/). *Biochemistry research international*. [Basic Science / Preclinical]
Kim KL (2026). [PMID: 42059171](https://pubmed.ncbi.nlm.nih.gov/42059171/). *Malays J Pathol*. [Basic Science / Preclinical]
Huang W (2026). [PMID: 41585174](https://pubmed.ncbi.nlm.nih.gov/41585174/). *Journal of dental sciences*. [Basic Science / Preclinical]
Huang F (2026). [PMID: 40590394](https://pubmed.ncbi.nlm.nih.gov/40590394/). *Cell proliferation*. [Basic Science / Preclinical]
Kamaraj C (2026). [PMID: 41836722](https://pubmed.ncbi.nlm.nih.gov/41836722/). *International journal of nanomedicine*. [Gene Therapy / Novel Therapeutics]
Yu L (2026). [PMID: 41753590](https://pubmed.ncbi.nlm.nih.gov/41753590/). *Microorganisms*. [Basic Science / Preclinical]
Panahipour L (2026). [PMID: 42099588](https://pubmed.ncbi.nlm.nih.gov/42099588/). *Front Immunol*. [Basic Science / Preclinical]
Ye Y (2026). [PMID: 42225948](https://pubmed.ncbi.nlm.nih.gov/42225948/). *Commun Biol*. [Basic Science / Preclinical]